Email Print Share
June 1, 2015

NSF spurs the translation of fundamental research into innovation through investments in biotech.

NSF spurs the translation of fundamental research into innovation through investment in high-tech small businesses and in broad-based, regional collaborations between academia and industry. Shown here is an image from GigaGen Inc., an NSF-funded small business that is creating novel natural antibody therapeutics. GigaGen is one of nearly 40 NSF grantees participating in the 2015 BIO Innovation Zone, an exhibit space dedicated to businesses with cutting-edge biomedical technologies supported by NSF's Directorate for Engineering.

Credit: GigaGen Inc.


Images credited to the National Science Foundation, a federal agency, are in the public domain. The images were created by employees of the United States Government as part of their official duties or prepared by contractors as "works for hire" for NSF. You may freely use NSF-credited images and, at your discretion, credit NSF with a "Courtesy: National Science Foundation" notation.

Additional information about general usage can be found in Conditions.

Also Available:
Download the high-resolution JPG version of the image. (862.9 KB)

Use your mouse to right-click (Mac users may need to Ctrl-click) the link above and choose the option that will save the file or target to your computer.

Related story: A buffet of emerging biotech at 2015 BIO Innovation Zone